Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Ache Laboratorios Farmaceuticos S.A. clinical trials
The registry lists 36 studies whose lead sponsor is Ache Laboratorios Farmaceuticos S.A.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Ache Laboratorios Farmaceuticos S.A. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ache Laboratorios Farmaceuticos S.A..
- Ache Laboratorios Farmaceuticos S.A.36 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 36 of 36.
- Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe PainNot yet recruitingNCT07880392Phase 3
- Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle GlaucomaNot yet recruitingNCT07617532Phase 3
- Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic HyperplasiaNot yet recruitingNCT07270432Phase 3
- Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic RhinitisNot yet recruitingNCT06577077Phase 3
- Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair LossNot yet recruitingNCT06355856Phase 4
- Efficacy and Safety of AS012 in Subjects With Non-segmental VitiligoCompletedNCT04487860Phase 2
- Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisCompletedNCT02582177Phase 3
- Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of InsomniaStatus unknownNCT02798367Phase 2/3
- To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.Status unknownNCT02985671Phase 3
- Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed DyslipidemiaCompletedNCT01420549Phase 3
- Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/FluSuspendedNCT02904304Phase 3
- Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.WithdrawnNCT03508167Phase 3
- Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially ControlledSuspendedNCT02853578Phase 3
- Cefalium® Compared to Tylenol® in the Treatment of Migraine AttacksSuspendedNCT02582996Phase 3
- Cefaliv® Compared to Neosaldina® in the Treatment of Migraine AttacksWithdrawnNCT02706015Phase 3
- Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy SubjectsStatus unknownNCT03634514Phase 4
- Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive CoughTerminatedNCT02581397Phase 3
- Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute RhinitisWithdrawnNCT01199497Phase 3
- Efficacy Study of Two Silicon-based Products to Treat ScarsWithdrawnNCT02584010Not applicable
- Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne VulgarisWithdrawnNCT02716090Phase 3
- Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPDWithdrawnNCT01393145Phase 3
- Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of RhinitisCompletedNCT01393548Phase 3
- ACH04 to Assess the Safety and Tolerability in Healthy Adults SubjectsCompletedNCT02949089Phase 1
- Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationCompletedNCT01392768Phase 3
- Study to Assess Tolerability, Safety and Pharmacokinetics of a New DrugTerminatedNCT01702675Phase 1
- Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of RhinitisCompletedNCT01393561Phase 3
- Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric SymptomsWithdrawnNCT01695616Phase 3
- Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of MigraineWithdrawnNCT01390324Phase 3
- Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years OldWithdrawnNCT00967759Phase 3
- Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute RhinitisWithdrawnNCT01177852Phase 3
- Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee OsteoarthritisCompletedNCT02409381Phase 4
- Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.WithdrawnNCT02713139Phase 3
- Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.WithdrawnNCT01726920Phase 3
- Efficacy and Safety of ACH24 in the Treatment of VitiligoWithdrawnNCT01419964Phase 3
- Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee OsteoarthritisCompletedNCT02010918Phase 3
- Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled AsthmaCompletedNCT01676987Phase 3